INNOVATIVE FEDERAL STRATEGIES, LLC for CERUS CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
H.R.4350/S.____, National Defense Authorization Act, 2022 - Title VII, all provisions related to blood safety.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERYNN D HOOK | — |
| CARL KIME | — |
| NEELY MARCUS SILBEY | — |
| LETITIA WHITE | — |
Budget/Appropriations BUD
H.R.____/S.____, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill, 2022 - Title II, all provisions related to blood safety. H.R.4432/S.____, Department of Defense Appropriations Bill, 2022 - Titles IV and VI, all provisions related to blood safety H.R.4355/S.____, Military Construction and Veterans Affairs Appropriations bill, 2022 - Title II, all provisions related to blood safety.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERYNN D HOOK | — |
| CARL KIME | — |
| NEELY MARCUS SILBEY | — |
| LETITIA WHITE | — |
Health Issues HCR
Contacted Department of Heath and Human Services officials regarding global efforts related to blood safety.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERYNN D HOOK | — |
| CARL KIME | — |
| NEELY MARCUS SILBEY | — |
| LETITIA WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.